normal phenotype
|
• no abnormal phenotype was observed including in the bile ducts
|
|
cn1
|
Jag1tm1.1Loo/Jag1tm1.1Loo Tg(Alb1-cre)1Khk/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
|
|||||||||||||||||
|
• no abnormal phenotype was observed including in the bile ducts
|
|
cn2
|
Jag1tm1.1Loo/Jag1+ Notch2tm1Grid/Notch2+ Tg(Alb1-cre)1Khk/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
|
|||||||||||||||||
|
• no abnormal phenotype was observed including in the bile ducts
|
|
cn3
|
Jag1tm1Grid/Jag1tm1.1Loo Tg(Alb1-cre)1Khk/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL |
|
|||||||||||||||||
|
• at 8 weeks of age, some mice have dilated bile tracts and expanded portal tracts
• cytokeratin staining also shows irregular, dilated ducts surrounding the periphery of many portal tracts
|
|
• bile stasis is identified within the lumina of several proliferating ducts
|
|
• diffuse bile duct proliferation is observed around small and large bile ducts by 4 weeks of age
• by 12 weeks of age, 50% of mice have bile duct proliferation with these ducts appearring small and slit-like
|
|
• at 8 weeks of age, some mice have dilated bile tracts and expanded portal tracts
• cytokeratin staining also shows irregular, dilated ducts surrounding the periphery of many portal tracts
|